Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Melanoma

  Free Subscription


19.03.2018

1 Am J Ophthalmol
2 Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Cutis
1 Int J Cancer
1 J Clin Oncol
1 J Invest Dermatol
1 J Surg Oncol
5 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. GLASGOW BJ, McCannel TA
    Correlation of immunocytochemistry of BRCA1-associated protein 1 (BAP1) with other prognostic markers in uveal melanoma.
    Am J Ophthalmol. 2018 Mar 9. pii: S0002-9394(18)30103.
    PubMed     Text format     Abstract available


    Cancer

  2. LEHRER S, Rheinstein PH, Rosenzweig KE
    Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31262.
    PubMed     Text format    

  3. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.
    Cancer. 2018 Mar 15. doi: 10.1002/cncr.31261.
    PubMed     Text format    


    Cancer Lett

  4. TANG J, Zhou H, Hou X, Wang L, et al
    Enhanced anti-tumor efficacy of temozolomide-loaded carboxylated poly(amido-amine) combined with photothermal/photodynamic therapy for melanoma treatment.
    Cancer Lett. 2018;423:16-26.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. OO ZY, Stevenson AJ, Proctor MA, Daignault SM, et al
    Endogenous replication stress marks melanomas sensitive to CHK1 inhibitors in vivo.
    Clin Cancer Res. 2018 Mar 13. pii: 1078-0432.CCR-17-2701.
    PubMed     Text format     Abstract available


    Cutis

  6. NERGARD-MARTIN J, Caldwell C, Barr M, Dellavalle RP, et al
    Perceptions of tanning risk among melanoma patients with a history of indoor tanning.
    Cutis. 2018;101:47.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. AITKEN JF, Youlden DR, Baade PD, Soyer HP, et al
    In response to: Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31347.
    PubMed     Text format    


    J Clin Oncol

  8. CARVAJAL RD, Piperno-Neumann S, Kapiteijn E, Chapman PB, et al
    Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
    J Clin Oncol. 2018 Mar 12:JCO2017741090. doi: 10.1200/JCO.2017.74.1090.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  9. PANDEYA N, Kvaskoff M, Olsen CM, Green AC, et al
    Factors related to nevus-associated cutaneous melanoma: a case-case study.
    J Invest Dermatol. 2018 Mar 7. pii: S0022-202X(18)30204.
    PubMed     Text format     Abstract available


    J Surg Oncol

  10. READ TA, Smith A, Thomas J, David M, et al
    Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study.
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.24921.
    PubMed     Text format     Abstract available


    Melanoma Res

  11. GESKIN LJ, Damiano JJ, Patrone CC, Butterfield LH, et al
    Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.
    Melanoma Res. 2018 Mar 14. doi: 10.1097/CMR.0000000000000441.
    PubMed     Text format     Abstract available

  12. DE UNAMUNO B, Garcia-Casado Z, Banuls J, Requena C, et al
    CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.
    Melanoma Res. 2018 Mar 14. doi: 10.1097/CMR.0000000000000442.
    PubMed     Text format     Abstract available

  13. STOWMAN AM, Hickman AW, Mauldin IS, Mahmutovic A, et al
    Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures.
    Melanoma Res. 2018 Mar 13. doi: 10.1097/CMR.0000000000000439.
    PubMed     Text format     Abstract available

  14. MIRZA S, Hill E, Ludlow SP, Nanjappa S, et al
    Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome.
    Melanoma Res. 2017;27:271-273.
    PubMed     Text format     Abstract available

  15. HAUEIS SA, Kranzlin P, Mangana J, Cheng PF, et al
    Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?
    Melanoma Res. 2017;27:231-237.
    PubMed     Text format     Abstract available


    PLoS One

  16. SHANKAR BABU M, Mahanta S, Lakhter AJ, Hato T, et al
    Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
    PLoS One. 2018;13:e0191419.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: